NOD2 regulates CXCR3-dependent CD8+ T cell accumulation in intestinal tissues with acute injury

Journal of Immunology

Volumn 192, Issue 7, 2014, Pages 3409-3418

  Wu, Xingxin ^a   Lahiri, Amit ^a   Haines III, G Kenneth ^a   Flavell, Richard A ^a,b   Abraham, Clara ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD3 ANTIBODY; CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENTEROPATHY; IMMUNOREGULATION; INTESTINE CELL; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LYMPHOCYTE MIGRATION; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; STROMA CELL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; BONE MARROW CELLS; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL10; CHEMOKINE CXCL9; COLITIS; DENDRITIC CELLS; FLOW CYTOMETRY; GENE EXPRESSION; INTERFERON-GAMMA; INTERLEUKIN-10; INTESTINES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, IMMUNOLOGICAL; NOD2 SIGNALING ADAPTOR PROTEIN; RECEPTORS, CXCR3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84897508343     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302436     Document Type: Article

References (40)

1. Abraham, C., and J. H. Cho. 2009. Inflammatory bowel disease. N. Engl. J. Med. 361: 2066-2078.
2. Shaw, M. H., T. Reimer, C. Sánchez-Valdepeñas, N. Warner, Y.-G. Kim, M. Fresno, and G. Nuñez. 2009. T cell-intrinsic role of Nod2 in promoting type 1 immunity to Toxoplasma gondii. Nat. Immunol. 10: 1267-1274.
3. Magalhaes, J. G., J. H. Fritz, L. Le Bourhis, G. Sellge, L. H. Travassos, T. Selvanantham, S. E. Girardin, J. L. Gommerman, and D. J. Philpott. 2008. Nod2-dependent Th2 polarization of antigen-specific immunity. J. Immunol. 181: 7925-7935.
4. van Beelen, A. J., Z. Zelinkova, E. W. Taanman-Kueter, F. J. Muller, D. W. Hommes, S. A. Zaat, M. L. Kapsenberg, and E. C. de Jong. 2007. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27: 660-669.
5. Han X., K. Uchida, I. Jurickova, D. Koch, T. Willson, C. Samson, E. Bonkowski, A. Trauernicht, M.O. Kim, G. Tomer, et al. 2009. Granulocyte- macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease. Gastroenterology. 136: 1261-1271, e1-3.
6. Kim, Y. G., M. H. Shaw, N. Warner, J. H. Park, F. Chen, Y. Ogura, and G. Núñez. 2011. Cutting edge: Crohn's disease-associated Nod2 mutation limits production of proinflammatory cytokines to protect the host from Enterococcus faecalisinduced lethality. J. Immunol. 187: 2849-2852.
7. Zeller, T., P. Wild, S. Szymczak, M. Rotival, A. Schillert, R. Castagne, S. Maouche, M. Germain, K. Lackner, H. Rossmann, et al. 2010. Genetics and beyond-the transcriptome of human monocytes and disease susceptibility. PLoS ONE 5: e10693.
8. Zhang, F. R., W. Huang, S. M. Chen, L. D. Sun, H. Liu, Y. Li, Y. Cui, X. X. Yan, H. T. Yang, R. D. Yang, et al. 2009. Genomewide association study of leprosy. N. Engl. J. Med. 361: 2609-2618.
9. Chatenoud, L., and J. A. Bluestone. 2007. CD3-specific antibodies: a portal to the treatment of autoimmunity. Nat. Rev. Immunol. 7: 622-632.
10. Herold, K. C., J. B. Burton, F. Francois, E. Poumian-Ruiz, M. Glandt, and J. A. Bluestone. 2003. Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3gamma1(Ala-Ala). J. Clin. Invest. 111: 409-418.
11. Merger, M., J. L. Viney, R. Borojevic, D. Steele-Norwood, P. Zhou, D. A. Clark, R. Riddell, R. Maric, E. R. Podack, and K. Croitoru. 2002. Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestine. Gut 51: 155-163.
12. Kamanaka, M., S. T. Kim, Y. Y. Wan, F. S. Sutterwala, M. Lara-Tejero, J. E. Galán, E. Harhaj, and R. A. Flavell. 2006. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 25: 941-952.
13. Waldron-Lynch F., O. Henegariu, S. Deng, P. Preston-Hurlburt, J. Tooley, R. Flavell, K.C. Herold. 2012. Teplizumab induces human gut-tropic regulatory cells in humanized mice and patients. Sci. Transl. Med. 4: 118ra112.
14. Esplugues, E., S. Huber, N. Gagliani, A. E. Hauser, T. Town, Y. Y. Wan, W. O'Connor, Jr., A. Rongvaux, N. Van Rooijen, A. M. Haberman, et al. 2011. Control of TH17 cells occurs in the small intestine. Nature 475: 514-518.
15. Huber, S., N. Gagliani, E. Esplugues, W. O'Connor, Jr., F. J. Huber, A. Chaudhry, M. Kamanaka, Y. Kobayashi, C. J. Booth, A. Y. Rudensky, et al. 2011. Th17 cells express interleukin-10 receptor and are controlled by Foxp3? and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity 34: 554-565.
16. Blázquez, A. B., A. K. Knight, H. Getachew, J. S. Bromberg, S. A. Lira, L. Mayer, and M. C. Berin. 2010. A functional role for CCR6 on proallergic T cells in the gastrointestinal tract. Gastroenterology 138: 275-284, e1-e4.
17. Zhang, J. L., D. J. Sun, C. M. Hou, Y. L. Wei, X. Y. Li, Z. Y. Yu, J. N. Feng, B. F. Shen, Y. Li, and H. Xiao. 2010. CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by up-regulation of Foxp3+ regulatory T cells in the target tissue: kidney. Transpl. Immunol. 24: 17-25.
18. Waldron-Lynch, F., S. Deng, P. Preston-Hurlburt, O. Henegariu, and K. C. Herold. 2012. Analysis of human biologics with a mouse skin transplant model in humanized mice. Am. J. Transplant. 12: 2652-2662.
19. Daifotis, A. G., S. Koenig, L. Chatenoud, and K. C. Herold. 2013. Anti-CD3 clinical trials in type 1 diabetes mellitus. Clin. Immunol. 149: 268-278.
20. Ochi, H., M. Abraham, H. Ishikawa, D. Frenkel, K. Yang, A. S. Basso, H. Wu, M. L. Chen, R. Gandhi, A. Miller, et al. 2006. Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25-LAP+ T cells. Nat. Med. 12: 627-635.
21. Rahman, M. K., E. H. Midtling, P. A. Svingen, Y. N. Xiong, M. P. Bell, J. Tung, T. Smyrk, L. J. Egan, and W. A. Faubion, Jr. 2010. The pathogen recognition receptor NOD2 regulates human FOXP3+ T cell survival. J. Immunol. 184: 7247-7256.
22. Rakoff-Nahoum, S., J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov. 2004. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241.
23. Marski, M., S. Kandula, J. R. Turner, and C. Abraham. 2005. CD18 is required for optimal development and function of CD4+CD25+ T regulatory cells. J. Immunol. 175: 7889-7897.
24. Wang, C., J. S. McDonough, K. G. McDonald, C. Huang, and R. D. Newberry. 2008. Alpha4beta7/MAdCAM-1 interactions play an essential role in transitioning cryptopatches into isolated lymphoid follicles and a nonessential role in cryptopatch formation. J. Immunol. 181: 4052-4061.
25. Bisikirska, B., J. Colgan, J. Luban, J. A. Bluestone, and K. C. Herold. 2005. TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. J. Clin. Invest. 115: 2904-2913.
26. Clayburgh, D. R., M. W. Musch, M. Leitges, Y. X. Fu, and J. R. Turner. 2006. Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo. J. Clin. Invest. 116: 2682-2694.
27. Villablanca, E. J., B. Cassani, U. H. von Andrian, and J. R. Mora. 2011. Blocking lymphocyte localization to the gastrointestinal mucosa as a therapeutic strategy for inflammatory bowel diseases. Gastroenterology 140: 1776-1784.
28. Groom, J. R., and A. D. Luster. 2011. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell Biol. 89: 207-215.
29. Abraham, C., and J. H. Cho. 2006. Functional consequences of NOD2 (CARD15) mutations. Inflamm. Bowel Dis. 12: 641-650.
30. Singh, U. P., S. Singh, D. D. Taub, and J. W. Lillard, Jr. 2003. Inhibition of IFNgamma-inducible protein-10 abrogates colitis in IL-10-/-mice. J. Immunol. 171: 1401-1406.
31. Berg, D. J., J. Zhang, J. V. Weinstock, H. F. Ismail, K. A. Earle, H. Alila, R. Pamukcu, S. Moore, and R. G. Lynch. 2002. Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology 123: 1527-1542.
32. Hyun, J. G., G. Lee, J. B. Brown, G. R. Grimm, Y. M. Tang, N. Mittal, R. Dirisina, Z. Zhang, J. P. Fryer, J. V. Weinstock, et al. 2005. Anti-interferoninducible chemokine, CXCL10, reduces colitis by impairing T helper-1 induction and recruitment in mice. Inflamm. Bowel Dis. 11: 799-805.
33. Penack, O., O. M. Smith, A. Cunningham-Bussel, X. Liu, U. Rao, N. Yim, I. K. Na, A. M. Holland, A. Ghosh, S. X. Lu, et al. 2009. NOD2 regulates hematopoietic cell function during graft-versus-host disease. J. Exp. Med. 206: 2101-2110.
34. Biswas, A., Y. J. Liu, L. Hao, A. Mizoguchi, N. H. Salzman, C. L. Bevins, and K. S. Kobayashi. 2010. Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum. Proc. Natl. Acad. Sci. USA 107: 14739-14744.
35. Jamontt, J., S. Petit, N. Clark, S. J. Parkinson, and P. Smith. 2013. Nucleotidebinding oligomerization domain 2 signaling promotes hyperresponsive macrophages and colitis in IL-10-deficient mice. J. Immunol. 190: 2948-2958.
36. Kim, Y.-G., N. Kamada, M. H. Shaw, N. Warner, G. Y. Chen, L. Franchi, and G. Núñez. 2011. The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes. Immunity 34: 769-780.
37. Magalhaes, J. G., S. J. Rubino, L. H. Travassos, L. Le Bourhis, W. Duan, G. Sellge, K. Geddes, C. Reardon, M. Lechmann, L. A. Carneiro, et al. 2011. Nucleotide oligomerization domain-containing proteins instruct T cell helper type 2 immunity through stromal activation. [Published erratum appears in 2012 Proc. Natl. Acad. Sci. USA 109: 10605.] Proc. Natl. Acad. Sci. USA 108: 14896-14901.
38. Sasaki, S., H. Yoneyama, K. Suzuki, H. Suriki, T. Aiba, S. Watanabe, Y. Kawauchi, H. Kawachi, F. Shimizu, K. Matsushima, et al. 2002. Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival. Eur. J. Immunol. 32: 3197-3205.
39. Hardi, R., L. Mayer, S. R. Targan, M. Yellin, P. M. Cardarelli, and K. M. Das. 2008. A phase 1 open-label, single-dose, dose-escalation study of Mdx-1100, a high-affinity, neutralizing, fully human Igg1 kappa anti-CXCL10 (Ip10) monoclonal antibody, in ulcerative colitis. Gastroenterology 134: A99-A100.
40. Masopust, D., V. Vezys, A. L. Marzo, and L. Lefrançois. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291: 2413-2417.